19 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
pipeline and build on the strong research and development capabilities we’ve established, and I look forward to continuing my engagement
DEF 14A
ar7jcp93emdb8
26 Apr 22
Definitive proxy
4:05pm
10-K
77xw801k
1 Mar 22
Annual report
4:07pm
424B4
s3374ibm0pfsp
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.19
un1he2z7lf7wxm9
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
totwpu5
18 Oct 21
IPO registration (amended)
6:04am
S-1
vdbslysm
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.19
0pfv6pl1jzveqd64flw2
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.20
3yyvr3
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.4
bwrf pwxjdef5t
1 Oct 21
IPO registration
4:49pm
DRS/A
EX-10.20
02eybevzv mzl5s8vdo
14 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
osgmn
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
EX-10.18
1iu6b63el081801hsoq
24 May 21
Draft registration statement
12:00am
DRS
7rxd5mw5k4q2wez1e
24 May 21
Draft registration statement
12:00am
DRS
EX-10.4
krkxv504mess0
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next